Joseph A Kaufman
Examiner (ID: 10129)
Most Active Art Unit | 3754 |
Art Unit(s) | 3752, 3993, 3727, 3754, 3108, 3104 |
Total Applications | 1964 |
Issued Applications | 1543 |
Pending Applications | 181 |
Abandoned Applications | 196 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5682584
[patent_doc_number] => 20060198854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Vector platforms derived from the alphavirus vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/319214
[patent_app_country] => US
[patent_app_date] => 2005-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10827
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198854.pdf
[firstpage_image] =>[orig_patent_app_number] => 11319214
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/319214 | Vector platforms derived from the alphavirus vaccines | Dec 27, 2005 | Abandoned |
Array
(
[id] => 5655866
[patent_doc_number] => 20060141602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Packaging of positive-strand RNA virus replicon particles'
[patent_app_type] => utility
[patent_app_number] => 11/297316
[patent_app_country] => US
[patent_app_date] => 2005-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17597
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141602.pdf
[firstpage_image] =>[orig_patent_app_number] => 11297316
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/297316 | Packaging of positive-strand RNA virus replicon particles | Dec 7, 2005 | Abandoned |
Array
(
[id] => 8921139
[patent_doc_number] => 08487076
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-07-16
[patent_title] => 'HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide'
[patent_app_type] => utility
[patent_app_number] => 11/814709
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6636
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11814709
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814709 | HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide | Dec 5, 2005 | Issued |
Array
(
[id] => 5415837
[patent_doc_number] => 20090041724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Protein Delivery System'
[patent_app_type] => utility
[patent_app_number] => 11/791917
[patent_app_country] => US
[patent_app_date] => 2005-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9380
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791917
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791917 | Protein Delivery System | Dec 4, 2005 | Abandoned |
Array
(
[id] => 509181
[patent_doc_number] => 07195915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-27
[patent_title] => 'Vectors for animal cells and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/284905
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14555
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/195/07195915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284905
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284905 | Vectors for animal cells and use thereof | Nov 22, 2005 | Issued |
Array
(
[id] => 5921283
[patent_doc_number] => 20060239972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Adiponectin gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/285689
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9712
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20060239972.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285689 | Adiponectin gene therapy | Nov 21, 2005 | Abandoned |
Array
(
[id] => 806595
[patent_doc_number] => 07419827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-02
[patent_title] => 'Cell lines'
[patent_app_type] => utility
[patent_app_number] => 11/283621
[patent_app_country] => US
[patent_app_date] => 2005-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12224
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/419/07419827.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283621
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283621 | Cell lines | Nov 20, 2005 | Issued |
Array
(
[id] => 5828154
[patent_doc_number] => 20060063234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Efficient production of IgM in recombinant mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 11/271090
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6733
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11271090
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/271090 | Efficient production of IgM in recombinant mammalian cells | Nov 8, 2005 | Abandoned |
Array
(
[id] => 5872858
[patent_doc_number] => 20060165658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/267275
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24929
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20060165658.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267275
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267275 | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof | Nov 6, 2005 | Abandoned |
Array
(
[id] => 6529754
[patent_doc_number] => 20100015211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Combination Approaches For Generating Immune Responses'
[patent_app_type] => utility
[patent_app_number] => 11/664962
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30881
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015211.pdf
[firstpage_image] =>[orig_patent_app_number] => 11664962
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/664962 | Combination Approaches For Generating Immune Responses | Oct 31, 2005 | Abandoned |
Array
(
[id] => 5141821
[patent_doc_number] => 20070004037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Methods and compositions for culturing keratinocytes'
[patent_app_type] => utility
[patent_app_number] => 11/258346
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11383
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004037.pdf
[firstpage_image] =>[orig_patent_app_number] => 11258346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/258346 | Methods and compositions for culturing keratinocytes | Oct 23, 2005 | Abandoned |
Array
(
[id] => 5674140
[patent_doc_number] => 20060179495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Tumor model with chromosomal rearrangement and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/255618
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11130
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20060179495.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255618
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255618 | Tumor model with chromosomal rearrangement and uses thereof | Oct 20, 2005 | Abandoned |
Array
(
[id] => 5726870
[patent_doc_number] => 20060057630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia'
[patent_app_type] => utility
[patent_app_number] => 11/256381
[patent_app_country] => US
[patent_app_date] => 2005-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21840
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057630.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256381
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256381 | MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia | Oct 19, 2005 | Abandoned |
Array
(
[id] => 5800445
[patent_doc_number] => 20060035371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Hybrid adeno-retroviral vector for the transfection of cells'
[patent_app_type] => utility
[patent_app_number] => 11/255059
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21667
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035371.pdf
[firstpage_image] =>[orig_patent_app_number] => 11255059
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/255059 | Hybrid adeno-retroviral vector for the transfection of cells | Oct 18, 2005 | Issued |
Array
(
[id] => 5760172
[patent_doc_number] => 20060211117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Methods of making minicircles'
[patent_app_type] => utility
[patent_app_number] => 11/249929
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 13538
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211117.pdf
[firstpage_image] =>[orig_patent_app_number] => 11249929
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/249929 | Methods of making minicircles | Oct 12, 2005 | Abandoned |
Array
(
[id] => 5655185
[patent_doc_number] => 20060140920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain'
[patent_app_type] => utility
[patent_app_number] => 11/244067
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12513
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140920.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244067
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244067 | Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain | Oct 5, 2005 | Abandoned |
Array
(
[id] => 5636945
[patent_doc_number] => 20060067918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Cell lines'
[patent_app_type] => utility
[patent_app_number] => 11/238702
[patent_app_country] => US
[patent_app_date] => 2005-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12168
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20060067918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238702
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238702 | Cell lines | Sep 28, 2005 | Issued |
Array
(
[id] => 5912959
[patent_doc_number] => 20060128021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Unusual retrotransposon from the yeast Candida albicans'
[patent_app_type] => utility
[patent_app_number] => 11/238031
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 113
[patent_figures_cnt] => 113
[patent_no_of_words] => 34547
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128021.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238031
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238031 | Unusual retrotransposon from the yeast Candida albicans | Sep 27, 2005 | Abandoned |
Array
(
[id] => 5820421
[patent_doc_number] => 20060024734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia'
[patent_app_type] => utility
[patent_app_number] => 11/233905
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21849
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024734.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233905
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233905 | MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia | Sep 21, 2005 | Abandoned |
Array
(
[id] => 5820508
[patent_doc_number] => 20060024821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Rolling circle replicon expression vector'
[patent_app_type] => utility
[patent_app_number] => 11/231725
[patent_app_country] => US
[patent_app_date] => 2005-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9313
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024821.pdf
[firstpage_image] =>[orig_patent_app_number] => 11231725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/231725 | Rolling circle replicon expression vector | Sep 19, 2005 | Abandoned |